Further investigations combining transcriptome profiling with high-resolution epigenome mapping in RCC can shed light on molecular mechanisms by which KDM5C contributes to ccRCC, and may lead to novel therapeutic interventions. This evidence concerns the gene KDM5C and renal cell carcinoma.